Sumer Jacquelyn L

Chief Legal OfficerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$34K
Net Open-Market Flow
-$34K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Sell(S)3K$9.67$34K135K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-327033) within minutes of acceptance. Every field above traces to the original document. Verify it directly: